The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women

Bruce M. Psaty; Susan R. Heckbert; David C. Atkins; Rozenn N. Lemaître; Thomas D. Koepsell; Patricia Wahl; David S. Siscovick; Edward H. Wagner

doi:10.1001/archinte.154.12.1333

Abstract

In this case-control study, the reduced risk of myocardial infarction associated with the use of estrogens alone was consistent with previous observational studies. Although the 95% confidence interval only excluded a risk above 1.22, the current use of combined therapy was not associated with an adverse effect on the incidence of myocardial infarction in postmenopausal women.

Keywords

Postmenopausal womenMedicineMyocardial infarctionInternal medicineProgestinEstrogenCardiologyPhysiology

Affiliated Institutions

Related Publications

Medroxyprogesterone Acetate Antagonizes Inhibitory Effects of Conjugated Equine Estrogens on Coronary Artery Atherosclerosis

Michael R. Adams , Thomas C. Register , Deborah L. Golden +2 more

Although estrogen replacement therapy is associated with reduced risk of coronary heart disease and reduced extent of coronary artery atherosclerosis, the effects of combined (e...

1997 Arteriosclerosis Thrombosis and Vascu... 372 citations

HORMONE REPLACEMENT THERAPY, HEART DISEASE, AND OTHER CONSIDERATIONS

Elizabeth Barrett‐Connor , Deborah Grady

▪ Abstract Multiple observational studies suggest a marked reduction in risk of coronary heart disease (CHD) associated with postmenopausal estrogen use. A new meta-analysis pre...

1998 Annual Review of Public Health 591 citations

A Case-Control Study of Myocardial Infarction in Relation to Use of Estrogen Supplements

Lynn Rosenberg , Julie R. Palmer , Samuel Shapiro

Observational epidemiologic studies suggest that the incidence of cardiovascular disease is reduced by about 50% in users of unopposed estrogens, but the reduction may have been...

1993 American Journal of Epidemiology 88 citations

Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial

Jacques E. Rossouw , Garnet L. Anderson , Ross L. Prentice +9 more

Overall health risks exceeded benefits from use of combined estrogen plus progestin for an average 5.2-year follow-up among healthy postmenopausal US women. All-cause mortality ...

2002 JAMA 15602 citations

Estrogen Replacement Therapy and Prognosis after First Myocardial Infarction

Katherine M. Newton , Andrea Z. LaCroix , Barbara McKnight +4 more

The effects of estrogen replacement therapy on prognosis in women with established coronary disease remain uncertain. The authors conducted a retrospective cohort study of 726 w...

1997 American Journal of Epidemiology 90 citations

Publication Info

Year: 1994
Type: article
Volume: 154
Issue: 12
Pages: 1333-1339
Citations: 278
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

278

OpenAlex

Cite This

APA Style

                            
                                
                                    Bruce M. Psaty, 
                                
                                    Susan R. Heckbert, 
                                
                                    David C. Atkins
                                
                                et al.
                            
                            (1994). 
                            The risk of myocardial infarction associated with the combined use of estrogens and progestins in postmenopausal women. 
                            Archives of Internal Medicine
                            , 154
                            (12)
                            , 1333-1339.
                            https://doi.org/10.1001/archinte.154.12.1333
                        

Identifiers

DOI: 10.1001/archinte.154.12.1333